⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 6, 2024Open Access

TABLE 2 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency

Aditya Kulkarni Jianli Zhou Neha Biyani Umesh Kathad Partha P. Banerjee Shiv Srivastava Zsombor Prucsi Kamil Solarczyk Kishor Bhatia Reginald B. Ewesuedo Panna Sharma

View Full Paper

Ask AI

Bookmark

Share

Abstract

LP-184 IC₅₀ in LMS cell lines. IC₅₀ was calculated from 72-hour cell viability assay. PTGR1 RNA expression was retrieved from the DepMap Public 23Q2 Primary Files. HR activity of these cell lines was reported in ref. 34

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kulkarni et al. (2024) studied this question.

synapsesocial.com/papers/68e6b5fbb6db643587637748 https://doi.org/10.1158/2767-9764.25757495.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1TABLE 2 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
2TABLE 1 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
3TABLE 1 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
4Supplementary Figure S11 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
5Supplementary Figure S11 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024

Supplementary Figure S6. from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
Supplementary Figure S6. from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
FIGURE 2 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024